Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Endocrine 1CNS 1

Conditions

Pheochromocytoma 1Neuroblastoma 1

Interventions

3-Iodobenzylguanidine 6fluorodopa F 18 2Ga(III)-DOTATOC 2surufatinib 1selpercatinib 1pegfilgrastim 1lutetium Lu 177 dotatate 1gallium Ga 68 dotatate 1Vorinostat 1Potassium Iodide 1Granulocyte Colony-Stimulating Factor 1Gallium-68 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Expanded_access × Potassium Iodide × Endocrine × Clear all
NCT03649438 2024-12-11

131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Relapsed/Refractory Neuroblastoma

University of Texas Southwestern Medical Center

No longer available
CNSEndocrine

Neuroblastoma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡